In reply: We thank Radford for his insightful comments, seasoned with spice from the frontline of primary care. Although guidelines are an accepted part of clinical practice, they are just recommendations and are not without their limitations. Treatments need to be individually tailored according to many factors. Our aim, therefore, was to provide a current snapshot of adherence to cardiovascular guidelines in primary care in Australia.1 It would be naive of us to think that there would be complete adherence to the guidelines in the “real world”. We wished to obtain an overall benchmark figure and, more importantly, identify treatment gaps or disparities in care across important patient subgroups defined by risk of cardiovascular event.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- The George Institute for International Health, Sydney, NSW.
- 1. Heeley EL, Peiris DP, Patel AA, et al. Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192: 254-259. <MJA full text>
- 2. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
- 3. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
- 4. Blood Pressure Lowering Treatment Trialists’ Collaboration; Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121-1123.
- 5. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists’ Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.